RNXT (STOCKS)
RenovoRx, Inc. Common Stock
$0.933100
-0.036900 (-3.80%)
Prev close: $0.970000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Shaun R. Bagai
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $34.45M
- Employees
- 10
- P/E (TTM)
- -2.62
- P/B (TTM)
- 4.40
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.08 | $-0.08 | +0.0016 | +1.96% |
|
Jun 2025 (Q2)
|
$-0.08 | $-0.09 | +0.0067 | +7.73% |
|
Mar 2025 (Q1)
|
$-0.08 | $-0.08 | +0.0016 | +1.96% |
|
Dec 2024 (Q4)
|
$-0.13 | $-0.11 | -0.0178 | -15.86% |
Financial Statements
| Revenues | $629.00K |
| Nonoperating Income/Loss | $515.00K |
| Operating Expenses | $12.25M |
| Selling, General, and Administrative Expenses | $5.92M |
| Research and Development | $6.34M |
| Operating Income/Loss | -$11.62M |
| Income/Loss From Continuing Operations After Tax | -$11.11M |
| Income/Loss From Continuing Operations Before Tax | -$11.11M |
| Net Income/Loss | -$11.11M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$11.11M |
| Net Income/Loss Available To Common Stockholders, Basic | -$11.11M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.36 |
| Diluted Earnings Per Share | -$0.36 |
| Basic Average Shares | 71,592,285 |
| Diluted Average Shares | 35,837,611 |
| Assets | $11.21M |
| Current Assets | $10.98M |
| Prepaid Expenses | $350.00K |
| Other Current Assets | $10.63M |
| Noncurrent Assets | $226.00K |
| Fixed Assets | $13.00K |
| Other Non-current Assets | $213.00K |
| Liabilities | $3.13M |
| Current Liabilities | $1.88M |
| Accounts Payable | $869.00K |
| Other Current Liabilities | $1.02M |
| Noncurrent Liabilities | $1.24M |
| Equity | $8.08M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $8.08M |
| Liabilities And Equity | $11.21M |
| Net Cash Flow From Operating Activities | -$10.38M |
| Net Cash Flow From Operating Activities, Continuing | -$10.38M |
| Net Cash Flow From Investing Activities | $5.49M |
| Net Cash Flow From Investing Activities, Continuing | $5.49M |
| Net Cash Flow From Financing Activities | $10.88M |
| Net Cash Flow From Financing Activities, Continuing | $10.88M |
| Net Cash Flow | $5.98M |
| Net Cash Flow, Continuing | $5.98M |
| Comprehensive Income/Loss | -$11.11M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$11.11M |
| Other Comprehensive Income/Loss | -$8.81M |